XML 37 R18.htm IDEA: XBRL DOCUMENT

Restructuring Charges	12 Months Ended
Restructuring Charges	Dec. 31, 2015
Restructuring Charges [Abstract]
Restructuring Charges	Note 11 — Restructuring Charges In December 2013, the Company announced a plan to significantly reduce its workforce by approximately 175 employees, from approximately 650 full-time employees, primarily in sales and marketing that were included in the Company's China segment. The restructuring was decided as a result of the non-renewal of the Company’s distribution agreement with Sanofi as of December 31, 2013. The decision resulted in severance-related charges of approximately $1.2 million recognized to restructuring expense in the consolidated statement of income for the year ended December 31, 2013.